Reuters logo
BRIEF-Transgene says first patient treated in a phase 1B/2 trial of TG4001
September 19, 2017 / 4:06 PM / in a month

BRIEF-Transgene says first patient treated in a phase 1B/2 trial of TG4001

Sept 19 (Reuters) - TRANSGENE SA:

* TRANSGENE: FIRST PATIENT TREATED IN A PHASE 1B/2 TRIAL OF TG4001 IN COMBINATION WITH AVELUMAB IN HPV-POSITIVE CANCERS

* ‍FIRST RESULTS EXPECTED IN 2018​ Source text for Eikon: Further company coverage: (Gdynia Newsroom:)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below